News und Analysen
Martin Midstream Partners Reports First Quarter 2022 Financial Results and Declares Quarterly Cash Distribution
Martin Midstream Partners L.P. (Nasdaq:MMLP) ("MMLP" or the "Partnership") today announced its financial results for the first quarter of 2022.
Bob Bondurant, President and Chief Executive
Customers Bancorp, Inc. Releases 2021 ESG Report
(April 20, 2022) - Customers Bancorp, Inc. (NYSE: CUBI), has released its Environmental, Social and Governance (ESG) Report for calendar year 2021. The report can be reviewed and downloaded from
Allied Motion Announces First Quarter 2022 Financial Results Conference Call and Webcast
Allied Motion Technologies Inc. (Nasdaq: AMOT) (“Allied Motion” or “Company”), a designer and manufacturer of precision and specialty controlled motion products and solutions for the global market,
Universal Insurance Holdings Declares Cash Dividend of 16 Cents per Share
Universal Insurance Holdings, Inc. (NYSE: UVE) (“Universal” or the “Company”) announced today that its Board of Directors declared a quarterly cash dividend of 16 cents per share of common stock
General American Investors Company, Inc. Quarterly Dividend and Distribution on 5.95% Preferred Stock
The Board of Directors of General American Investors Company, Inc., a closed-end investment company listed on the New York Stock Exchange (GAM), declared on its 5.95% cumulative preferred stock
SynBiotic SE and Enchilada Group: Joint venture to launch first cannabis store in Germany
Mexico’s Megacable Selects Verimatrix Streamkeeper and XTD Products To Further Strengthen Security
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that Megacable, one of Mexico’s
DGAP-News: Corestate presents unqualified audit opinion and publishes Annual Report 2021
DGAP-Adhoc: Corestate Capital Holding S.A.: CORESTATE with audited financial statements for 2021
Gurit reports net sales of CHF 107.7 million in the first quarter of 2022
ISG Launches ISG Women in Digital Awards Program
Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, today announced the launch of the ISG Women in Digital Awards program, recognizing women and
Upland Software to Release First Quarter Financial Results on May 4
Upland Software, Inc. (Nasdaq: UPLD) today announced it will release financial results for the first quarter after market close on Wednesday, May 4, 2022. A conference call will follow at 4:00 p.m
DGAP-Adhoc: init innovation in traffic systems SE: Completion of share buyback
Inseego Corp. to Report First Quarter 2022 Financial Results on May 4, 2022
Inseego Corp. (Nasdaq: INSG), a leader in 5G and intelligent IoT device-to-cloud solutions, will release financial results for the quarter ended March 31, 2022 on Wednesday, May 4, 2022.
Inseego
Clovis Oncology to Announce First Quarter 2022 Financial Results and Host Webcast Conference Call on May 4
Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its first quarter 2022 financial results on Wednesday, May 4, 2022, before the open of the US financial markets. Clovis’ senior management will
STAAR Surgical to Report First Quarter Results on May 4, 2022
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release
Healthcare Services Group, Inc. Reports Q1 2022 Results
Healthcare Services Group, Inc. (NASDAQ:HCSG) (the “Company”) reported for the three months ended March 31, 2022 revenue of $426.8 million and net income of $11.3 million, or $0.15 per basic and
Navidea Biopharmaceuticals Announces Updated Third-Party Asset Valuation of Tc99m Tilmanocept for Indications in Rheumatoid Arthritis for U.S. and EU Markets
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today
Navidea Biopharmaceuticals Announces Positive Preliminary Results of Its Ongoing Phase 2B Study Comparing Tc99m Tilmanocept Imaging with Histopathology of Joints from Patients with Rheumatoid Arthritis
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today